Biosimilars Market Poised for Substantial Growth by 2031, Driven by Rising Chronic Disease Prevalence
29 janv. 2024 12h36 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user,...
Biosimilar Insulin Market Global Industry Analysis - Market Set to Surge, Spearheaded by High Demand in APAC and Cost-Effective Innovations
29 janv. 2024 12h24 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Biosimilar Insulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Biosimilars in Oncology - Pricing is a Key Issue for Biosimilars Entering an Increasingly Crowded Market
23 janv. 2024 10h38 HE
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thematic Intelligence - Biosimilars in oncology" report has been added to ResearchAndMarkets.com's offering.The report provides an insight into the...
Lyophilization Services for Biopharmaceuticals Market to Reach $2.45 Billion by 2027, Driven by Growing Biologics Demand
23 janv. 2024 01h18 HE
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Lyophilization Services For Biopharmaceuticals Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global...
Biopharmaceutical Industry Emerging Technologies, Trends and Macroeconomic Factors to Dominate in 2024: Cell and Gene Therapies will be the Key Focus in 2024
17 janv. 2024 11h38 HE
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2024 Edition" report has been added to ResearchAndMarkets.com's offering.While the fight against COVID-19 is...
Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review 2023
14 déc. 2023 05h48 HE
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...
Global Biosimilars Market Analysis 2023-2028 - Increasing Access, Adoption, and Awareness are the Key to Future Growth Potential of Biosimilars
02 nov. 2023 07h53 HE
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Global Biosimilars Market, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. Rising Confidence...
Growing Implementation of Process Analytical Technology to Drive the Global Upstream Bioprocessing Market 2023-2030
25 sept. 2023 07h43 HE
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Global Upstream Bioprocessing Market by Product, Workflow, Use Type, Mode - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation...
Unlocking the Potential: Investment in R&D Drives Oncology Biosimilars Growth 2023
21 sept. 2023 07h48 HE
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global oncology biosimilars market...
[Latest] Global Recombinant Human Insulin Market Size/Share Worth USD 55.99 Billion by 2032 at a 8.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
25 août 2023 16h30 HE
|
Custom Market Insights
Austin, TX, USA, Aug. 26, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Recombinant Human Insulin Market Size, Trends and Insights By Product (Regular...